Mapping large numbers of results may take a few moments.
Search Results
Showing 451 - 495 of 495 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Torque Bio Inc. | Activity: Research and Development | Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. | Location Durham |
| |
Company Traitology | Activity: Research and Development | Company Description Traitology uses computational biology, combined with new breeding technologies, to develops plant traits that improve yields, extend growing seasons, and make crops more resilient to climate change and disease. | Location Research Triangle Park |
| |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary |
| |
Company TransChromix LLC | Activity: Research and Development | Company Description TransChromix is developing novel therapeutic inventions for chronic inflammation-associated diseases, such as Type 1 diabetes and Alzheimer's disease. | Location Chapel Hill |
| |
Company TransViragen Inc. | Activity: Contract Research and Testing | Company Description TransViragen provides in vivo discovery research services, including the generation and analysis of genetically modified rodents and cell lines. | Location Chapel Hill |
| |
Company TreeCo | Activity: Research and Development | Company Description TreeCo is using CRISPR technology, combining tree genetics with genome editing, to enhance trees for the forestry industry and the environment. | Location Raleigh |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company Triangle Biotechnology Inc. | Activity: Research and Development | Company Description Triangle Biotechnology develops sonication reagents that enable efficient acoustic processing of biological samples for next generation sequencing and epigenetic assays. | Location Research Triangle Park |
| |
Company TriboFilm Research Inc. | Activity: Research and Development | Company Description TriboFilm Research develops low-friction, thin-film coating and lubrication platforms for medical devices. | Location Raleigh |
| |
Company TyraTech Inc. | Activity: Research and Development | Company Description TyraTech develops and commercializes plant-derived non-toxic insecticides and green solutions for humans, animals and agricultural applications. | Location Morrisville |
| |
Company Ummino | Activity: Research and Development | Company Description Ummino is developing technology that uses precision fermentation to fortify food and beverage products and restore and repair the microbiome. | Location Raleigh |
| |
Company UPL (Cary) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions, including biological, crop protection, seed treatment and post-harvest technologies covering the entire agricultural value chain. | Location Cary |
| |
Company UPL OpenAg Center (RTP) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions across the agricultural value chain. The OpenAg Center contains climate-controlled greenhouses and laboratories and will partner with collaborating companies to develop resistance products. | Location Research Triangle Park |
| |
Company Upstream Biotechnology Inc. | Activity: Research and Development | Company Description Upstream Biotechnology uses patented technology to develop broad-spectrum disease resistant crops to eliminate pesticide use, reduce production cost and increase crop yield. | Location Sanford |
| |
Company URO-1 Inc. | Activity: Research and Development | Company Description URO-1 develops breakthrough products for office procedures for urology and urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency. | Location Greensboro |
| |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham |
| |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham |
| |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham |
| |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville |
| |
Company Verb Biotics LLC | Activity: Research and Development | Company Description Verb Biotics identifies and designs new strains of probiotics and postbiotics for nutrition, health and wellness. | Location Durham |
| |
Company Verdesian Life Sciences LLC (Cary) | Activity: Research and Development | Company Description Verdesian Life Sciences develops agricultural products with a focus in plant health, inoculants, seed treatment and nutrition. | Location Cary |
| |
Company Verdesian Life Sciences LLC (RTP) | Activity: Research and Development | Company Description Verdesian Life Sciences' lab in RTP focuses on the exploration of emerging and disruptive technologies to improve plant nutrient use efficacy, agriculture productivity and environmental sustainability. | Location Research Triangle Park |
| |
Company Verinetics Inc. | Activity: Research and Development | Company Description Verinetics is commercializing platform technology that makes dispensing controlled substance pharmaceuticals safer for patients and their providers. | Location Research Triangle Park |
| |
Company Vero Diagnostics LLC | Activity: Contract Research and Testing | Company Description Vero Diagnostics offers comprehensive diagnostic testing, including urine and oral fluid drug monitoring, pathogen detection, Pharmacogenomics (PGx) testing and blood testing. | Location Apex |
| |
Company Viamer Biosciences | Activity: Research and Development | Company Description Viamer Biosciences develops advanced and proprietary biomaterials for controlled release drug delivery and regenerative medical devices. | Location Durham |
| |
Company Vijaya Pharmaceuticals LLC | Activity: Contract Research and Testing | Company Description Vijaya Pharmaceuticals provides medicinal and synthetic organic chemistry services to the pharmaceutical and allied industries. | Location Research Triangle Park |
| |
Company ViraSource LLC | Activity: Contract Research and Testing | Company Description ViraSource propagates and purifies BSL-1, BSL-2 viruses and bacteriophages. ViraSource also provides virus modifications and animal models of viral infections and antiviral immune responses. | Location Durham |
| |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham |
| |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh |
| |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing technologies to produce large quantities of hepatocytes (liver cells) on demand for cell therapy, regenerative medicine and pharmaceutical applications. | Location Charlotte |
| |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Xenobiotic Detection Systems International Inc. | Activity: Contract Research and Testing | Company Description Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks. | Location Durham |
| |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |
| |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park |
| |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary |
| |
Company Xyzagen Inc. | Activity: Contract Research and Testing | Company Description Xyzagen is a non-GLP LC-MS/MS bioanalytical lab with rodent in vivo pharmacokinetics and pharmacology research vivarium. Xyzagen also offers clinical pharmacology/pharmokinetics and GLP toxicokinetic support. | Location Pittsboro |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |
| |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh |
| |
Company Zorbius Biopharma Inc. | Activity: Contract Research and Testing | Company Description Zorbius Biopharma provides analytical, formulation and nanotechnology-related services to pharmaceutical, biotech and medical device companies. | Location Morrisville |
| |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park |
| |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |
| |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |